Join ELRIG for our latest networking event “Latest Developments in CRISPR Technology for Functional Genomics in Oncology” to be held at Homerton College, Cambridge.
CRISPR/Cas9 technology is becoming one of the key drug discovery techniques supporting the validation of novel targets, the search for new targets, and the development of new ways to model disease, including critically overcoming drug resistance in cancer.
Hear speakers from academia and AstraZeneca discuss the latest developments in CRISPR/Cas9 technology and how it can be applied in an oncology pipeline.
Steve Rees (ELRIG Chair, AstraZeneca)
Luke Gilbert (UCFS)
Following the presentations, there will be a complimentary food and drinks reception, giving further networking opportunities. We look forward to welcoming you to Cambridge on the 7th of December.
Venue: Homerton College
Location: 184 Hills Road
Country: United Kingdom
Organiser Contact Details:
T: 07484 email@example.com